Population pharmacokinetics of teicoplanin in infants and children

Bibliographic Information

Other Title
  • 小児におけるteicoplaninの母集団薬物動態解析

Search this article

Abstract

We analyzed teicoplanin (TEIC) pharmacokinetics in infants and children using the nonlinear mixed effects model (NONMEM) to estimate population pharmacokinetics parameters. Subjects were 63 children (28 days to 16 years old) prescribed TEIC at Kitasato University Hospital and undergoing therapeutic drug monitoring. Population pharmacokinetics parameters were calculated using 1-compartment model of clearance (CLTEIC) and volume of distribution (VdTEIC). An exponential error model was used to determine interindividual variability and a relative error model for residual variability. Patient age, gender, weight, serum creatinine, and serum albumin were covariates. The observed TEIC serum concentration was 101 points ranging from 4.4-39.1ug/mL. TEIC population pharmacokinetics parameters finally estimated were: CLTEIC=0.00836×(wt/Scr) 0786 (L/h) and VdTEIC=0.8× wt (L). Interindividual variability was CLTEIC=26.7 (%) and VdTEIC=32.7 (%), and residual variability was 2.8, μg/mL. CLTEIC changes due to aging correlated well with that of kidney gravity. Model validity was sufficient. Our reports suggest that the population parameters are useful in evaluating TEIC pharmacokinetics in children undergoing long-term hospitalization.

Journal

Citations (1)*help

See more

References(10)*help

See more

Details 詳細情報について

Report a problem

Back to top